New scanner aims to spot blood vessel inflammation more clearly
NCT ID NCT07628075
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study will test a new type of PET/CT scanner, called Long-Axial Field-of-View (LAFOV), to see if it can better detect inflammation in the walls of large arteries in people with large vessel vasculitis (LVV). The scanner is more sensitive and can image the whole body faster, potentially allowing for lower radiation doses and clearer pictures. Researchers will compare scans from 18 participants (12 with LVV and 6 healthy volunteers) to develop a standardized imaging protocol for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS (GCA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Imperial College Healthcare NHS Trust
London, Greater London, W2 1NY, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
King's College London
London, Greater London, SE1 7EH, United Kingdom
Contact
Contact Email: •••••@•••••
-
Royal Free London NHS Foundation Trust
London, Greater London, NW3 2QG, United Kingdom
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
[18F]FDG (a radioactive sugar) and CT contrast dye
What this could lead to
If successful, this could lead to a standardized, more accurate imaging protocol for diagnosing and monitoring large vessel vasculitis, potentially reducing unnecessary treatments.
What could go wrong
This is a small, early-phase study (18 participants) focused on optimizing the imaging technique, not testing a treatment. The new method may not prove significantly better than current scans.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.